243 related articles for article (PubMed ID: 16158445)
21. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
22. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
23. Time-of-day dependent pharmacodynamic and pharmacokinetic profiles of caffeine in rats.
Pelissier-Alicot AL; Schreiber-Deturmeny E; Simon N; Gantenbein M; Bruguerolle B
Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):318-25. PubMed ID: 11919657
[TBL] [Abstract][Full Text] [Related]
24. Discriminative stimulus properties of nicotine at low doses: the effects of caffeine preload.
Duka T; Tasker R; Russell K; Stephens DN
Behav Pharmacol; 1998 May; 9(3):219-29. PubMed ID: 9832936
[TBL] [Abstract][Full Text] [Related]
25. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects.
Conte JE; Golden JA; McIver M; Zurlinden E
Int J Antimicrob Agents; 2006 Aug; 28(2):114-21. PubMed ID: 16837169
[TBL] [Abstract][Full Text] [Related]
26. [Pharmacokinetics of fudosteine in healthy volunteers].
Ding L; Yang J; Li RS; Zhou M; Shen JP; Zhang YD
Yao Xue Xue Bao; 2005 Oct; 40(10):945-9. PubMed ID: 16408815
[TBL] [Abstract][Full Text] [Related]
27. Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss.
Dinges DF; Arora S; Darwish M; Niebler GE
Curr Med Res Opin; 2006 Jan; 22(1):159-67. PubMed ID: 16393442
[TBL] [Abstract][Full Text] [Related]
28. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
[TBL] [Abstract][Full Text] [Related]
29. Effect of repeated caffeine ingestion on repeated exhaustive exercise endurance.
Bell DG; McLellan TM
Med Sci Sports Exerc; 2003 Aug; 35(8):1348-54. PubMed ID: 12900689
[TBL] [Abstract][Full Text] [Related]
30. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.
Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W
Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293
[TBL] [Abstract][Full Text] [Related]
31. The appetite-suppressant effect of nicotine is enhanced by caffeine.
Jessen A; Buemann B; Toubro S; Skovgaard IM; Astrup A
Diabetes Obes Metab; 2005 Jul; 7(4):327-33. PubMed ID: 15955118
[TBL] [Abstract][Full Text] [Related]
32. Caffeine effects on recovery sleep following 27 h total sleep deprivation.
LaJambe CM; Kamimori GH; Belenky G; Balkin TJ
Aviat Space Environ Med; 2005 Feb; 76(2):108-13. PubMed ID: 15742825
[TBL] [Abstract][Full Text] [Related]
33. Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness.
Killgore WD; Rupp TL; Grugle NL; Reichardt RM; Lipizzi EL; Balkin TJ
J Sleep Res; 2008 Sep; 17(3):309-21. PubMed ID: 18522689
[TBL] [Abstract][Full Text] [Related]
34. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.
Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS
Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104
[TBL] [Abstract][Full Text] [Related]
35. Caffeine-induced hyperactivity in the horse: comparisons of drug and metabolite concentrations in blood and cerebrospinal fluid.
Vickroy TW; Chang SK; Chou CC
J Vet Pharmacol Ther; 2008 Apr; 31(2):156-66. PubMed ID: 18307508
[TBL] [Abstract][Full Text] [Related]
36. Effects of repeated doses of caffeine on performance and alertness: new data and secondary analyses.
Hewlett P; Smith A
Hum Psychopharmacol; 2007 Aug; 22(6):339-50. PubMed ID: 17514640
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult volunteers.
Darwish M; Kirby M; Robertson P; Tracewell W; Jiang JG
Clin Ther; 2006 May; 28(5):707-14. PubMed ID: 16861092
[TBL] [Abstract][Full Text] [Related]
38. Effects of repeated doses of caffeine on mood and performance of alert and fatigued volunteers.
Smith A; Sutherland D; Christopher G
J Psychopharmacol; 2005 Nov; 19(6):620-6. PubMed ID: 16272184
[TBL] [Abstract][Full Text] [Related]
39. Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers.
Shah J; Wesnes KA; Kovelesky RA; Henney HR
Clin Ther; 2006 Sep; 28(9):1308-17. PubMed ID: 17062304
[TBL] [Abstract][Full Text] [Related]
40. Absolute bioavailability of sitagliptin, an oral dipeptidyl peptidase-4 inhibitor, in healthy volunteers.
Bergman A; Ebel D; Liu F; Stone J; Wang A; Zeng W; Chen L; Dilzer S; Lasseter K; Herman G; Wagner J; Krishna R
Biopharm Drug Dispos; 2007 Sep; 28(6):315-22. PubMed ID: 17575559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
